Axsome Therapeutics (AXSM) Current Assets (2022 - 2025)
Historic Current Assets for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $565.3 million.
- Axsome Therapeutics' Current Assets rose 1799.76% to $565.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $565.3 million, marking a year-over-year increase of 1799.76%. This contributed to the annual value of $485.1 million for FY2024, which is 380.73% down from last year.
- Axsome Therapeutics' Current Assets amounted to $565.3 million in Q3 2025, which was up 1799.76% from $536.6 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Current Assets registered a high of $565.3 million during Q3 2025, and its lowest value of $86.8 million during Q1 2022.
- Its 4-year average for Current Assets is $400.9 million, with a median of $479.1 million in 2024.
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 39980.53% in 2023, then crashed by 1090.25% in 2024.
- Axsome Therapeutics' Current Assets (Quarter) stood at $245.6 million in 2022, then skyrocketed by 105.28% to $504.3 million in 2023, then fell by 3.81% to $485.1 million in 2024, then rose by 16.55% to $565.3 million in 2025.
- Its Current Assets was $565.3 million in Q3 2025, compared to $536.6 million in Q2 2025 and $494.6 million in Q1 2025.